Global Market News

Pharma defeats biotech push for rapid approval program

2/2/2012

Biotechs butted heads with their far-larger pharmaceutical allies over a key lobbying issue, and lost. As Bloomberg reports, biotechnology companies threw their weight behind a plan drafted by North Carolina Democratic Sen. Kay Hagan to launch a more rapid FDA approval program, using fewer human trials, for orphan drugs or treatments that address fatal diseases. Pharmaceutical companies beat back the measure, however, apparently not wanting to dilute existing safety measures
 

Fierce BioTech



Return to Previous Page

Today Is:
Wednesday, April 23, 2014


April Events

<< >>
SMTWTFS
12345
6789101112
13141516171819
20212223242526
27282930